SCHEMBL25587653

SCHEMBL25587653

CC(C)(C)S(=O)(=O)N1CCCC1c1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 1/20 0.42
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CXCR4 P61073 2/20 0.39
▸ PIK3C3 Q8NEB9 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ COMT P21964 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ POLB P06746 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25587646 1.00 RIPK1 (0.42) RIPK1PRMT5WDR77CYP3A4CYP2C19
SCHEMBL25587652 1.00 RIPK1 (0.42) RIPK1PRMT5WDR77CYP3A4CYP2C19
SCHEMBL24015591 0.85 GCK (0.45) RIPK1PRMT5WDR77CYP3A4CYP2C19
SCHEMBL26465261 0.85 GCK (0.45) RIPK1PRMT5WDR77CYP3A4CYP2C19
SCHEMBL24015604 0.85 GCK (0.45) RIPK1PRMT5WDR77CYP3A4CYP2C19
SCHEMBL25592087 0.84 CXCR4 (0.36) RIPK1PRMT5WDR77CYP3A4CYP2C19
SCHEMBL7491275 0.79 GAA (0.61) CYP3A4CYP2C19SMN1; SMN2CYP1A2CYP2C9
SCHEMBL25587656 0.79 RIPK1 (0.52) RIPK1CYP3A4CYP2C19LMNAHSD11B1
SCHEMBL25587630 0.79 RIPK1 (0.52) RIPK1CYP3A4CYP2C19LMNAHSD11B1
SCHEMBL25587628 0.79 RIPK1 (0.52) RIPK1CYP3A4CYP2C19LMNAHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 — — US disclosed
US-20230278958-A1 TRICYCLIC HETEROCYCLES MERCK PATENT GMBH (DE) 2023-09-07 — — US disclosed
US-20230174538-A1 Tricyclic heterocycles MERCK PATENT GMBH (DE) 2023-06-08 — — US disclosed
US-20230174538-A1 Tricyclic heterocycles MERCK PATENT GMBH (DE) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278958-A1 TRICYCLIC HETEROCYCLES YAP1, TERF2IP, TEAD1 RIPK1 595/4885PRMT5 1041/4885WDR77 2343/4885
US-20230174538-A1 Tricyclic heterocycles YAP1, TEAD1, TERF2IP RIPK1 639/4885PRMT5 945/4885WDR77 2401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback